Search In this Thesis
   Search In this Thesis  
العنوان
Screening of Human Cytomegalo Virus among Voluntary
Blood Donors
/
المؤلف
Gad El-Rub,Nagwa Basyouni Ahmad .
هيئة الاعداد
باحث / نجوى بسيونى أحمد جاد الرب
مشرف / سحر سمير عبدالمقصود
مشرف / رشا عبدالرحمن عبداللطيف
تاريخ النشر
2017.
عدد الصفحات
150.p;
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب (متفرقات)
تاريخ الإجازة
1/4/2017
مكان الإجازة
جامعة عين شمس - كلية الطب - Clinical and Chemical Pathology
الفهرس
Only 14 pages are availabe for public view

from 150

from 150

Abstract

Background: Blood transfusion represents a potentially life-saving intervention with well-known benefits & risks. Transfusion transmitted infections (TTI) are a great concern of safety for patients. Aim of the Work: The aim of this study is to determining the prevalence of CMV infection among voluntary blood donors using PCR technique to guarantee that the blood bank would offer the safest blood units attainable. Subjects and Methods: This study carried out between the months of June and November in 2013 at blood bank of Ain Shams University hospitals on 50 voluntary blood donors. The study population consisted of 50 consecutive voluntary blood donors of different blood groups with different social classes. They were 25 males (13 from them under 40 years and 12 above 40 years) and 25 females (13 from them under 40 years and 12 above 40 years). Their ages ranged from 18 years to 55 years with a mean of 31.35±9.09 SD years. Results: The current study showed a statistically significant difference between CMV cytomegalovirus according to social class. Conclusion: Despite a high incidence rate of HCMV infection was reported in this study among voluntary eligible blood donors, the routine screening of blood donors for HCMV infection in such a resource limited environment not feasible. However, the HCMV free blood could be a source of the needed blood for immunosuppressed patients. Recommendations: An inventory CMV DNA negative blood should be kept in blood bank as a source of needed blood for immunocompromised patients.